. 2012 Apr 2;33(5):606–614. doi: 10.1038/aps.2012.6

Table 2. Both Ro-31-8220 and PD 98059 inhibited high-glucose-induced proliferation of VSMCs. ^aP>0.05, ^cP<0.01 vs normal glucose (5 mmol/L) group. ^fP<0.01 vs high glucose (25 mmol/L) group.

	Absorbance value
Normal Glucose (5 mmol/L)	0.442±0.021
High Glucose (25 mmol/L)	0.669±0.025^c
High Glucose+Breviscapine (108 mmol/L)	0.441±0.025^af
High Glucose+Ro-31-8220 (3 μmol/L)	0.385±0.026^af
High Glucose+PD 98059 (25 μmol/L)	0.453±0.020^af
Normal Glucose+Ro-31-8220 (3 μmol/L)	0.391±0.022^a
Normal Glucose+PD 98059 (25 μmol/L)	0.449±0.021^a

Table 2. Both Ro-31-8220 and PD 98059 inhibited high-glucose-induced proliferation of VSMCs. aP>0.05, cP<0.01 vs normal glucose (5 mmol/L) group. fP<0.01 vs high glucose (25 mmol/L) group.